Photo taken from: Agenus/LinkedIn
Oct 11, 2023, 22:39
Agenus completed the planned patient enrollment of its Phase 2 clinical trial evaluating investigational agents botensilimab (BOT) and balstilimab (BAL) in advanced colorectal cancer. – Agenus
Agenus, made the following post on LinkedIn:
“Agenus completed the planned patient enrollment of its Phase 2 clinical trial evaluating investigational agents botensilimab (BOT) and balstilimab (BAL) in advanced colorectal cancer.”
For details click here.
Source: Agenus/LinkedIn
Aug 14, 2024, 03:41